TBPH CIK: 1583107

Theravance Biopharma, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.25
FY22:
0.35
FY23:
0.13
FY24:
0.16
FY25:
0.42
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.12
FY22:
0.25
FY23:
0.25
FY24:
0.19
FY25:
0.07
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.37
FY22:
0.61
FY23:
0.38
FY24:
0.35
FY25:
0.49

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.06
FY22:
0.03
FY23:
0.02
FY24:
0.03
FY25:
0.04
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.65
FY22:
0.14
FY23:
0.14
FY24:
0.15
FY25:
0.15
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.34
FY22:
0.44
FY23:
0.21
FY24:
0.18
FY25:
0.30
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.37
FY22:
0.61
FY23:
0.38
FY24:
0.35
FY25:
0.49

All amounts in billions USD Data sources:SEC EDGARTwelve Data